Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
August 03 2023 - 6:20AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
PROXY
STATEMENT PURSUANT TO SECTION 14(A) OF THE
SECURITIES
EXCHANGE ACT OF 1934 (Amendment No. )
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
|
|
☐ |
Confidential,
For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
☐ |
Definitive
Proxy Statement |
|
|
☒ |
Definitive
Additional Materials |
|
|
☐ |
Soliciting
Materials Under §240. 14a-12 |
|
BONE
BIOLOGICS CORPORATION |
|
|
(Name
of Registrant as Specified in its Charter) |
|
|
|
|
|
|
|
|
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant) |
|
Payment
of Filing Fee (Check all boxes that apply):
☐ |
Fee
paid previously with preliminary materials. |
|
|
☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Bone Biologics (NASDAQ:BBLG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bone Biologics (NASDAQ:BBLG)
Historical Stock Chart
From Jul 2023 to Jul 2024